drugset / Trial / NCT01554917
A Study of Iguratimod in Patients With Active Rheumatoid Arthritis
NaSingle-groupOpen-labelTreatment
Summary
This study is intended to evaluate the safety and efficacy of Iguratimod in patients with active Rheumatoid Arthritis.
Timeline
- Start
- 2012-05
- Primary completion
- 2015-08
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iguratimod | Small molecule | 25 mg | Oral |